Top Markets
Coin of the day
Oncoinvent ASA Oncoinvent ASA

Oncoinvent ASA

ONCIN
Rangering i aksjer #26813
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Aksjekurs
$8.39
Markedsverdi
$37.55M
Endring (1 dag)
-7.83%
Endring (1 år)
-26.06%
Land
NO
Handel Oncoinvent ASA (ONCIN)

Kategori

Utbyttehistorikk for Oncoinvent ASA (ONCIN)
Oncoinvent ASA (aksjesymbol: ONCIN) har gitt totalt 0 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): 0.00
Utbytteavkastning (TTM): 0
Utbyttebetalinger for Oncoinvent ASA (ONCIN) fra 2026 til 2026
Årlige utbyttebetalinger
År Utbytte (justert for aksjesplitt) Endre
Ikke nok data for de angitte datoene.
Liste over alle utbyttebetalinger
År Utbytte Endre
Ikke nok data for de angitte datoene.
Utbyttebetalinger for lignende selskaper eller konkurrenter
Selskap Antall utbyttebetalinger Land
0.00%
US
0.00%
US
0.00%
NL
64.00%
AU
0.00%
CH